These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 4052933

  • 1. Hairy cell leukemia. Durability of response to splenectomy in 26 patients and treatment of relapse with androgens in six patients.
    Magee MJ, McKenzie S, Filippa DA, Arlin ZA, Gee TS, Clarkson BD.
    Cancer; 1985 Dec 01; 56(11):2557-62. PubMed ID: 4052933
    [Abstract] [Full Text] [Related]

  • 2. Splenectomy for hairy cell leukaemia.
    Ingoldby CJ, Ackroyd N, Catovsky D, Spencer J.
    Clin Oncol; 1981 Dec 01; 7(4):325-31. PubMed ID: 7318275
    [No Abstract] [Full Text] [Related]

  • 3. Long-term results in hairy cell leukemia treated by splenectomy.
    Chrobák L, Podzimek K, Kerekes Z, Spacek J, Voglová J.
    Neoplasma; 1993 Dec 01; 40(2):133-6. PubMed ID: 8350957
    [Abstract] [Full Text] [Related]

  • 4. [Clinical aspects of hairy cell leukemia and its modification by splenectomy].
    Rojo J, Glöckner WM.
    Onkologie; 1982 Oct 01; 5(5):216-21. PubMed ID: 6760022
    [Abstract] [Full Text] [Related]

  • 5. Recombinant alpha-2 interferon for treatment of hairy cell leukemia without prior splenectomy.
    Ehmann WC, Silber R.
    Am J Med; 1986 Jun 01; 80(6):1111-4. PubMed ID: 3728508
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Results of treatment in patients with hairy cell leukemia with splenectomy, alpha-interferon and deoxycoformycin].
    Gotić M, Rolović Z, Radosević N, Draguljac N, Jovanović V, Bogdanović A, Bosković D.
    Srp Arh Celok Lek; 2000 Jun 01; 128(7-8):262-70. PubMed ID: 11089434
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The history of hairy cell leukemia: characteristics of long-term survivors.
    Bouroncle BA.
    Semin Oncol; 1984 Dec 01; 11(4 Suppl 2):479-85. PubMed ID: 6505709
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Recombinant alpha-2 interferon in the treatment of hairy cell leukemia.
    Thompson JA, Brady J, Kidd P, Fefer A.
    Cancer Treat Rep; 1985 Dec 01; 69(7-8):791-3. PubMed ID: 4016788
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Elevations in serum soluble interleukin-2 receptor levels predict relapse in patients with hairy cell leukemia.
    Arun B, Curti BD, Longo DL, Stevens D, Alvord WG, Gause BL, Watson T, Kopp WC, Janik JE.
    Cancer J Sci Am; 2000 Dec 01; 6(1):21-4. PubMed ID: 10696734
    [Abstract] [Full Text] [Related]

  • 19. Splenectomy for the treatment of hairy-cell leukemia.
    Eldar S, Kemeny MM, Benfield JR.
    Surg Gynecol Obstet; 1982 Dec 01; 155(6):829-32. PubMed ID: 7147163
    [Abstract] [Full Text] [Related]

  • 20. Hairy cell leukemia. A therapeutical update.
    Damasio EE, Pagnucco G, Federico M, Annino L, Chisesi T, Lamparelli T, Lauria F, Castoldi G, Resegotti L.
    Haematologica; 1989 Dec 01; 74(2):205-18. PubMed ID: 2473014
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.